DB
CYTO

Danske Bank’s Altamira Therapeutics Ltd CYTO Stock Holding History

Danske Bank’s Portfolio CYTO Stock Details CYTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1
Closed -$1 – 1699
2024
Q3 		$1 Buy
+1
New +$1 ﹤0.01% 1605

Other funds holding CYTO

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Danske Bank's CYTO Position: Q4 2024 in Review

Danske Bank sold out of Altamira Therapeutics Ltd (CYTO) in Q4 2024, closing a stake of 1 share — an estimated $1 sold.

Danske Bank first reported a position in CYTO in Q3 2024 and held it in 1 quarter. The position peaked at $1 in Q3 2024. 2 funds tracked by Wall St. Rank hold CYTO as of Q4 2024.

  • Danske Bank reported no remaining Altamira Therapeutics Ltd position as of Q4 2024 after selling out during the quarter.
  • Danske Bank sold 1 Altamira Therapeutics Ltd share in Q4 2024, an estimated $1.
  • Danske Bank first reported a position in Altamira Therapeutics Ltd in Q3 2024 and held it in 1 quarter.
  • Danske Bank's Altamira Therapeutics Ltd position peaked at $1 in Q3 2024.
  • 2 funds tracked by Wall St. Rank held Altamira Therapeutics Ltd as of Q4 2024.

Based on Danske Bank's 13F filing for Q4 2024, filed 18 Mar 2026.